US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 6.110
  • +0.110+1.83%
Close May 15 16:00 ET
420.40MMarket Cap-2578P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-19.15%3.04M
-33.25%20.76M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-32.08%31.1M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
Operating revenue
-19.15%3.04M
-33.25%20.76M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-32.08%31.1M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
Cost of revenue
Gross profit
Operating expense
-17.92%32.82M
-0.52%159.79M
-1.12%40.69M
-0.92%38.88M
-2.39%40.23M
2.47%39.99M
25.57%160.63M
16.45%41.15M
19.81%39.24M
29.22%41.22M
Selling and administrative expenses
-6.00%10.29M
-1.65%42.08M
-1.89%10.3M
9.96%10.53M
4.15%10.31M
-14.63%10.95M
28.67%42.79M
19.51%10.5M
13.33%9.58M
14.91%9.9M
-General and administrative expense
-6.00%10.29M
-1.65%42.08M
-1.89%10.3M
9.96%10.53M
4.15%10.31M
-14.63%10.95M
28.67%42.79M
19.51%10.5M
13.33%9.58M
14.91%9.9M
Research and development costs
-22.41%22.53M
-0.11%117.71M
-0.85%30.39M
-4.44%28.35M
-4.46%29.93M
10.83%29.04M
24.48%117.84M
15.45%30.65M
22.06%29.66M
34.51%31.32M
Operating profit
17.79%-29.78M
-7.33%-139.03M
2.26%-37.43M
14.41%-27.81M
-37.19%-37.57M
-15.49%-36.23M
-57.71%-129.53M
-151.02%-38.29M
-33.95%-32.49M
-23.82%-27.38M
Net non-operating interest income expense
166.44%3.86M
520.97%8.44M
166.25%2.95M
351.89%2.4M
5,978.57%1.65M
676.89%1.45M
177.30%1.36M
374.94%1.11M
223.54%530K
93.97%-28K
Non-operating interest income
87.83%3.86M
174.46%9.81M
72.62%2.95M
136.35%2.56M
343.87%2.25M
644.20%2.05M
823.77%3.58M
1,156.62%1.71M
885.45%1.08M
633.33%506K
Non-operating interest expense
--0
-38.04%1.37M
--0
-69.86%167K
12.36%600K
14.99%606K
3.31%2.22M
11.50%601K
2.78%554K
0.19%534K
Other net income (expense)
-2.44M
-621K
0
-621K
Special income (charges)
---2.44M
---621K
--0
---621K
----
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
--2.44M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
----
--621K
--0
--621K
----
----
----
----
----
----
Income before tax
18.46%-28.36M
-2.37%-131.21M
7.28%-34.48M
18.54%-26.03M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
Income tax
0
1.28M
277K
1M
0
0
0
0
Net income
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
Net income continuous Operations
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
Minority interest income
Net income attributable to the parent company
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
Basic earnings per share
42.25%-0.41
-1.91%-2.67
10.53%-0.68
15.38%-0.55
-30.36%-0.73
-9.23%-0.71
-43.96%-2.62
-145.16%-0.76
-27.45%-0.65
-9.80%-0.56
Diluted earnings per share
42.25%-0.41
-1.91%-2.67
10.53%-0.68
15.38%-0.55
-30.36%-0.73
-9.23%-0.71
-43.96%-2.62
-145.16%-0.76
-27.45%-0.65
-9.80%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -19.15%3.04M-33.25%20.76M14.26%3.26M63.93%11.07M-80.74%2.66M-50.89%3.76M-32.08%31.1M-85.79%2.85M-20.54%6.75M41.44%13.83M
Operating revenue -19.15%3.04M-33.25%20.76M14.26%3.26M63.93%11.07M-80.74%2.66M-50.89%3.76M-32.08%31.1M-85.79%2.85M-20.54%6.75M41.44%13.83M
Cost of revenue
Gross profit
Operating expense -17.92%32.82M-0.52%159.79M-1.12%40.69M-0.92%38.88M-2.39%40.23M2.47%39.99M25.57%160.63M16.45%41.15M19.81%39.24M29.22%41.22M
Selling and administrative expenses -6.00%10.29M-1.65%42.08M-1.89%10.3M9.96%10.53M4.15%10.31M-14.63%10.95M28.67%42.79M19.51%10.5M13.33%9.58M14.91%9.9M
-General and administrative expense -6.00%10.29M-1.65%42.08M-1.89%10.3M9.96%10.53M4.15%10.31M-14.63%10.95M28.67%42.79M19.51%10.5M13.33%9.58M14.91%9.9M
Research and development costs -22.41%22.53M-0.11%117.71M-0.85%30.39M-4.44%28.35M-4.46%29.93M10.83%29.04M24.48%117.84M15.45%30.65M22.06%29.66M34.51%31.32M
Operating profit 17.79%-29.78M-7.33%-139.03M2.26%-37.43M14.41%-27.81M-37.19%-37.57M-15.49%-36.23M-57.71%-129.53M-151.02%-38.29M-33.95%-32.49M-23.82%-27.38M
Net non-operating interest income expense 166.44%3.86M520.97%8.44M166.25%2.95M351.89%2.4M5,978.57%1.65M676.89%1.45M177.30%1.36M374.94%1.11M223.54%530K93.97%-28K
Non-operating interest income 87.83%3.86M174.46%9.81M72.62%2.95M136.35%2.56M343.87%2.25M644.20%2.05M823.77%3.58M1,156.62%1.71M885.45%1.08M633.33%506K
Non-operating interest expense --0-38.04%1.37M--0-69.86%167K12.36%600K14.99%606K3.31%2.22M11.50%601K2.78%554K0.19%534K
Other net income (expense) -2.44M-621K0-621K
Special income (charges) ---2.44M---621K--0---621K------0--0--0--0----
-Less：Restructuring and merger&acquisition --2.44M------------------0----------------
-Less:Other special charges ------621K--0--621K------------------------
Income before tax 18.46%-28.36M-2.37%-131.21M7.28%-34.48M18.54%-26.03M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M-29.47%-31.96M-21.40%-27.41M
Income tax 01.28M277K1M0000
Net income 18.46%-28.36M-3.37%-132.49M6.54%-34.75M15.40%-27.04M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M-29.47%-31.96M-21.40%-27.41M
Net income continuous Operations 18.46%-28.36M-3.37%-132.49M6.54%-34.75M15.40%-27.04M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M-29.47%-31.96M-21.40%-27.41M
Minority interest income
Net income attributable to the parent company 18.46%-28.36M-3.37%-132.49M6.54%-34.75M15.40%-27.04M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M-29.47%-31.96M-21.40%-27.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.46%-28.36M-3.37%-132.49M6.54%-34.75M15.40%-27.04M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M-29.47%-31.96M-21.40%-27.41M
Basic earnings per share 42.25%-0.41-1.91%-2.6710.53%-0.6815.38%-0.55-30.36%-0.73-9.23%-0.71-43.96%-2.62-145.16%-0.76-27.45%-0.65-9.80%-0.56
Diluted earnings per share 42.25%-0.41-1.91%-2.6710.53%-0.6815.38%-0.55-30.36%-0.73-9.23%-0.71-43.96%-2.62-145.16%-0.76-27.45%-0.65-9.80%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg